Relapse

Oncology·MeSH: Recurrence

287 drugs in development·117 companies·5 clinical trials

Drug Pipeline by Phase

Approved(35)

Drug	Company
ABRAXANE	ImmunityBio, Inc. (IBRX)
arsenic tri	NEXUS BIOPHARMA INC (NEXS)
aucatzyl	Autolus Therapeutics plc (AUTL)
bortezomib	Teva Pharmaceutical Industries Limited (TEVA)
carmustine	Amneal Pharmaceuticals, Inc. (AMRX)
clofarabine	Mersana Therapeutics, Inc. (MRSN)
clofarabine	DR REDDYS LABORATORIES LTD (RDY)
danyelza	Y-mAbs Therapeutics, Inc. (YMAB)
imatinib	SUNSET ISLAND GROUP (SUN)
imatinib	Teva Pharmaceutical Industries Limited (TEVA)
imatinib	DR REDDYS LABORATORIES LTD (RDY)
imatinib	Mylan II B.V. (MYL)
imatinib	Aptinyx Inc. (APTX)
imatinib	Amneal Pharmaceuticals, Inc. (AMRX)
imkeldi	CG Oncology, Inc. (CGON)
jaypirca	LOXO ONCOLOGY, INC. (LOXO)
Jaypirca	ELI LILLY & Co (LLY)
Jaypirca®	ELI LILLY & Co (LLY)
komzifti	Kura Oncology, Inc. (KURA)
LYMPHIR (denileukin diftitox-cdxl)	CITIUS ONCOLOGY, INC. (CTOR)
methotrexate	ELITE PHARMACEUTICALS INC /NV/ (ELTP)
Monjuvi	Xencor Inc (XNCR)
nelarabine	NEXUS BIOPHARMA INC (NEXS)
nelarabine	Amneal Pharmaceuticals, Inc. (AMRX)
ojemda	Day One Biopharmaceuticals, Inc. (DAWN)
ojemda	XOMA Royalty Corporation (XOMA)
paclitaxel	Mylan II B.V. (MYL)
Revuforj	Syndax Pharmaceuticals Inc (SNDX)
rezlidhia	RIGEL PHARMACEUTICALS INC (RIGL)
Tyvyt	ELI LILLY & Co (LLY)
Tyvyt®	ELI LILLY & Co (LLY)
VIVITROL	Alkermes plc. (ALKS)
xpovio	Karyopharm Therapeutics Inc. (KPTI)
zydelig	GILEAD SCIENCES, INC. (GILD)
ZYNLONTA (loncastuximab tesirine)	ADC Therapeutics SA (ADCT)

Phase 3(59)

Drug	Company
alxn2075	ALEXION PHARMACEUTICALS, INC. (ALXN)
Amrubicin	Merus N.V. (MRUS)
anitocabtagene autoleucel	GILEAD SCIENCES, INC. (GILD)
aNK	ImmunityBio, Inc. (IBRX)
bb2121	CELGENE CORP /DE/ (CELG)
bexobrutideg	Nurix Therapeutics, Inc. (NRIX)
bgb-21447	BeOne Medicines Ltd. (ONC)
Blinatumomab	ENANTA PHARMACEUTICALS INC (ENTA)
bortezomib	AbbVie Inc. (ABBV)
carfilzomib	Sanofi (SNY)
Carfilzomib	BRISTOL MYERS SQUIBB CO (BMY)
chemotherapy agents	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
Clofarabine	Jazz Pharmaceuticals plc (JAZZ)
daratumumab	ASTRAZENECA PLC (AZN)
daratumumab	Juno Therapeutics, Inc. (JUNO)
daratumumab	REGENERON PHARMACEUTICALS, INC. (REGN)
Daratumumab	BRISTOL MYERS SQUIBB CO (BMY)
elotuzumab	REGENERON PHARMACEUTICALS, INC. (REGN)
hmpl-760	HUTCHMED (China) Ltd (HMDCF)
HMPL-760	ENANTA PHARMACEUTICALS INC (ENTA)
Inotuzumab	ENANTA PHARMACEUTICALS INC (ENTA)
ixazomib	X4 Pharmaceuticals, Inc (XFOR)
kte-c19	Kite Pharma, Inc. (KITE)
liso-cel	CELGENE CORP /DE/ (CELG)
Liso-cel	BRISTOL MYERS SQUIBB CO (BMY)
Lurbinectedin	Merus N.V. (MRUS)
Lurbinectedin	Crinetics Pharmaceuticals, Inc. (CRNX)
Melphalan	Filana Therapeutics Inc. (FLNA)
Mesna	Filana Therapeutics Inc. (FLNA)
Mezigdomide	BRISTOL MYERS SQUIBB CO (BMY)
montelukast	Sanofi (SNY)
Montelukast	Sanofi (SNY)
obinutuzumab	GH Research PLC (GHRS)
obinutuzumab	BeOne Medicines Ltd. (ONC)
Obinutuzumab	BeOne Medicines Ltd. (ONC)
olverembatinib	CHINA PHARMA HOLDINGS, INC. (CPHI)
Orelabrutinib	Merus N.V. (MRUS)
Pomalidomide	BeOne Medicines Ltd. (ONC)
Pomalidomide	Merus N.V. (MRUS)
Pomalidomide	BRISTOL MYERS SQUIBB CO (BMY)
r-gemox	HUTCHMED (China) Ltd (HMDCF)
R-GemOx	ENANTA PHARMACEUTICALS INC (ENTA)
regn5459	REGENERON PHARMACEUTICALS, INC. (REGN)
Rocbrutinib	Merus N.V. (MRUS)
Roginolisib	ENANTA PHARMACEUTICALS INC (ENTA)
rondecabtagene autoleucel	Lyell Immunopharma, Inc. (LYEL)
sonrotoclax	BeOne Medicines Ltd. (ONC)
Sonrotoclax	ENANTA PHARMACEUTICALS INC (ENTA)
tak-007	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
teclistamab	GH Research PLC (GHRS)
Teclistamab	Merus N.V. (MRUS)
teclistamab monotherapy	GH Research PLC (GHRS)
Thiotepa	Filana Therapeutics Inc. (FLNA)
tirabrutinib	West Pharmaceutical Services Inc. (WST)
tirabrutinib	Eton Pharmaceuticals, Inc. (ETON)
tirabrutinib	Deciphera Pharmaceuticals, Inc. (DCPH)
Topotecan	Crinetics Pharmaceuticals, Inc. (CRNX)
uproleselan	Apollomics Inc. (APLM)
Zanubrutinib	Merus N.V. (MRUS)

Phase 2(55)

Drug	Company
ALLO-501	Allogene Therapeutics, Inc. (ALLO)
ALLO-501A	Allogene Therapeutics, Inc. (ALLO)
ALLO-647	Allogene Therapeutics, Inc. (ALLO)
allo-715	Allogene Therapeutics, Inc. (ALLO)
anti-cd20 car-t	CELLULAR BIOMEDICINE GROUP, INC. (CMBG)
AUCATZYL/obe-cel	Autolus Therapeutics plc (AUTL)
Bendamustine	FATE THERAPEUTICS INC (FATE)
CAR BCMA-CD70-T cells	Merus N.V. (MRUS)
CAR BCMA-CD70-T cells	Filana Therapeutics Inc. (FLNA)
CD19 t-haNK- IV Administration	ImmunityBio, Inc. (IBRX)
CD19t-haNK suspension	ImmunityBio, Inc. (IBRX)
Cyclophophamide	Allogene Therapeutics, Inc. (ALLO)
cyt-0851	Cyteir Therapeutics, Inc. (CYT)
emavusertib	CURIS INC (CRIS)
Emavusertib (CA-4948)	CURIS INC (CRIS)
EOS-448	iTeos Therapeutics, Inc. (ITOS)
Filgrastim	Filana Therapeutics Inc. (FLNA)
Fludarabine	FATE THERAPEUTICS INC (FATE)
Fludarabine	Allogene Therapeutics, Inc. (ALLO)
GM-CSF	UNITED THERAPEUTICS Corp (UTHR)
haNK	ImmunityBio, Inc. (IBRX)
hu14.18K322A	Black Diamond Therapeutics, Inc. (BDTX)
hu14.18K322A	Filana Therapeutics Inc. (FLNA)
hu14.18K322A	PTC THERAPEUTICS, INC. (PTCT)
iberdomide	CELGENE CORP /DE/ (CELG)
impt-314	Lyell Immunopharma, Inc. (LYEL)
incb001158	Incyte Corp. (INCY)
incb059872	Incyte Corp. (INCY)
Inotuzumab ozogamicin	ENANTA PHARMACEUTICALS INC (ENTA)
Loncastuximab tesirine	ENANTA PHARMACEUTICALS INC (ENTA)
Mivavotinib (CB-659)	Calithera Biosciences, Inc. (CALA)
mt-401-ots	Marker Therapeutics, Inc. (MRKR)
N803	Filana Therapeutics Inc. (FLNA)
N803	PTC THERAPEUTICS, INC. (PTCT)
N803	Black Diamond Therapeutics, Inc. (BDTX)
n803 plus bacillus calmette-guerin	ImmunityBio, Inc. (IBRX)
nexi-001	NexImmune, Inc. (NEXI)
nexi-002	NexImmune, Inc. (NEXI)
Obe-cel (AUTO1)	Autolus Therapeutics plc (AUTL)
Part 1	FATE THERAPEUTICS INC (FATE)
Part 2	FATE THERAPEUTICS INC (FATE)
Pirtobrutinib	Filana Therapeutics Inc. (FLNA)
Pirtobrutinib	ENANTA PHARMACEUTICALS INC (ENTA)
r-gemox	HUTCHMED (China) Limited (HCM)
rtx-224	Rubius Therapeutics, Inc. (RUBY)
rtx-240	Rubius Therapeutics, Inc. (RUBY)
Sargramostim	PTC THERAPEUTICS, INC. (PTCT)
sl-701	STEMLINE THERAPEUTICS INC (STML)
stenoparib	Allarity Therapeutics, Inc. (ALLR)
t-haNK	ImmunityBio, Inc. (IBRX)
Temozolomide	ELI LILLY & Co (LLY)
trichostatin a	Vanda Pharmaceuticals Inc. (VNDA)
UCART123v1.2	Cellectis S.A. (CLLS)
vcar33	Vor Biopharma Inc. (VOR)
Zanubrutinib	ENANTA PHARMACEUTICALS INC (ENTA)

Phase 1(85)

Drug	Company
[14C]ABT-199	AbbVie Inc. (ABBV)
ABT-199	AbbVie Inc. (ABBV)
ACLX-001	Arcellx, Inc. (ACLX)
ACLX-002	Arcellx, Inc. (ACLX)
ADCLEC.syn1 CAR T cells	Merus N.V. (MRUS)
ADCT-602	ADC Therapeutics SA (ADCT)
Anti-STEAP1 CAR T-cells	Filana Therapeutics Inc. (FLNA)
apg-3288	ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
ARV-393	ARVINAS, INC. (ARVN)
ATA3219	Atara Biotherapeutics, Inc. (ATRA)
aur107	PRF Technologies Ltd. (PRFX)
AUTO6NG	Autolus Therapeutics plc (AUTL)
Autologous BCMA-targeting CAR T cells	Filana Therapeutics Inc. (FLNA)
Autologous CCR4 CAR T cells	Merus N.V. (MRUS)
Autologous CCR4 CAR T cells	Filana Therapeutics Inc. (FLNA)
B7-H3-CAR T Cells	Merus N.V. (MRUS)
BP1002	BIO-PATH HOLDINGS, INC. (BPTH)
Carfilzomib	Merus N.V. (MRUS)
CB-010	Caribou Biosciences, Inc. (CRBU)
CB-011	Caribou Biosciences, Inc. (CRBU)
CB-012	Caribou Biosciences, Inc. (CRBU)
cd19 t-hank	ImmunityBio, Inc. (IBRX)
cd19-car t-cells	GH Research PLC (GHRS)
cd19t-hank	ImmunityBio, Inc. (IBRX)
CLN-049	Cullinan Therapeutics, Inc. (CGEM)
CLN-619	Cullinan Therapeutics, Inc. (CGEM)
Cytarabine	Syndax Pharmaceuticals Inc (SNDX)
diphenhydramine	Sanofi (SNY)
DVX201 (Unmodified Natural Killer Cells)	Coeptis Therapeutics Holdings Inc. (COEP)
E7777 (LYMPHIR) prior to CAR-T	CITIUS ONCOLOGY, INC. (CTOR)
Efbalropendekin alfa (XmAb306 / RG6323)	Xencor Inc (XNCR)
epcoritamab	Genmab A/S (GMAB)
Epcoritamab	Filana Therapeutics Inc. (FLNA)
Epcoritamab	ENANTA PHARMACEUTICALS INC (ENTA)
Epcoritamab	ELI LILLY & Co (LLY)
EXS73565	RECURSION PHARMACEUTICALS, INC. (RXRX)
Filgrastim	AbbVie Inc. (ABBV)
Fludarabine	NEKTAR THERAPEUTICS (NKTR)
Fludarabine	ImmunityBio, Inc. (IBRX)
FT522	FATE THERAPEUTICS INC (FATE)
gtb-3650	GT Biopharma, Inc. (GTBP)
hec89736	SUNSHINE BIOPHARMA INC. (SBFM)
Hyper-CVAD	ENANTA PHARMACEUTICALS INC (ENTA)
Hyper-CVAD	Merus N.V. (MRUS)
Imetelstat	Assertio Holdings, Inc. (ASRT)
jnj-79635322	GH Research PLC (GHRS)
jnj-87562761	GH Research PLC (GHRS)
jnj-90009530	GH Research PLC (GHRS)
KT-253	Kymera Therapeutics, Inc. (KYMR)
KT-333	Kymera Therapeutics, Inc. (KYMR)
kur-501	Athenex, Inc. (ATNX)
LCAR-AIO T cells	Legend Biotech Corp (LEGN)
lisaftoclax	ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
Loncastuximab tesirine	ADC Therapeutics SA (ADCT)
LUCAR-DKS1 NK cells	Legend Biotech Corp (LEGN)
LUCAR-G79 T cells	Legend Biotech Corp (LEGN)
LYMPHIR (investigator-initiated: pre-CAR-T)	CITIUS ONCOLOGY, INC. (CTOR)
mb-109	MUSTANG BIO, INC. (MBIO)
me-344	Lite Strategy, Inc. (LITS)
Mesna	Structure Therapeutics Inc. (GPCR)
Mini-hyper-CVD	ENANTA PHARMACEUTICALS INC (ENTA)
Mini-hyper-CVD	Merus N.V. (MRUS)
mk-4002	Merck & Co., Inc. (MRK)
mt-6402	Molecular Templates, Inc. (MTEM)
N803	ImmunityBio, Inc. (IBRX)
nc525	NextCure, Inc. (NXTC)
nirogacestat	Allogene Therapeutics, Inc. (ALLO)
nxc-201	Immix Biopharma, Inc. (IMMX)
olverembatinib	ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
Revumenib	Syndax Pharmaceuticals Inc (SNDX)
sar445514	Sanofi (SNY)
sar445514	Sanofi (SNYNF)
sc-daric33	2seventy bio, Inc. (TSVT)
sgr-1505	Schrodinger, Inc. (SDGR)
sgr-2921	Schrodinger, Inc. (SDGR)
sti-1492	Sorrento Therapeutics, Inc. (SRNE)
tazemetostat	Epizyme, Inc. (EPZM)
Tazemetostat	Merus N.V. (MRUS)
tti-621	Trillium Therapeutics Inc. (TRIL)
tti-622	Trillium Therapeutics Inc. (TRIL)
vispa-cel	Caribou Biosciences, Inc. (CRBU)
Vyxeos 44 MG / 100 MG Liposome Injection	Jazz Pharmaceuticals plc (JAZZ)
zelebrudomide	Nurix Therapeutics, Inc. (NRIX)
zelenirstat	UNITED THERAPEUTICS Corp (UTHR)
ZN-d5	Zentalis Pharmaceuticals, Inc. (ZNTL)

Preclinical(6)

Drug	Company
ACLX-004	Arcellx, Inc. (ACLX)
al101	OLD AYALA, INC (AYLA)
BCR-ABL TKI	Theseus Pharmaceuticals, Inc. (THRX)
Pan-mutant BRAF degrader program (proprietary)	Nurix Therapeutics, Inc. (NRIX)
Pan-mutant BRAF program (mutant BRAF degraders)	Nurix Therapeutics, Inc. (NRIX)
VETO CAR-T	Cell Source, Inc. (CLCS)

Unknown(3)

Drug	Company
LCAR- F33S cells intravenous infusion	Legend Biotech Corp (LEGN)
puzolcabtagene autoleucel	PRECISION BIOSCIENCES INC (DTIL)
uproleselan	CRESCENT BIOPHARMA, INC. (CBIO)

Phase 1/Phase 2(33)

Drug	Company
abexinostat	XYNOMIC PHARMACEUTICALS HOLDINGS, INC. (BCACU)
auto1	Autolus Therapeutics plc (AUTL)
AUTO1/22	Autolus Therapeutics plc (AUTL)
azd0120	ALEXION PHARMACEUTICALS, INC. (ALXN)
bendamustine	Karyopharm Therapeutics Inc. (KPTI)
Carfilzomib	BeOne Medicines Ltd. (ONC)
daratumumab	Genmab A/S (GMAB)
daratumumab	GENMAB A/S (GNMSF)
daratumumab	BeOne Medicines Ltd. (ONC)
Daratumumab	BeOne Medicines Ltd. (ONC)
daratumumab sc	Incyte Corp. (INCY)
Dinutuximab	ELI LILLY & Co (LLY)
Fimepinostat	CURIS INC (CRIS)
fludarabine	Lyell Immunopharma, Inc. (LYEL)
gen3014	Genmab A/S (GMAB)
gen3014	GENMAB A/S (GNMSF)
glpg5101	Galapagos NV (GLPG)
GLPG5101	Galapagos NV (GLPG)
GM-CSF	ELI LILLY & Co (LLY)
linvoseltamab	REGENERON PHARMACEUTICALS, INC. (REGN)
lisaftoclax	CHINA PHARMA HOLDINGS, INC. (CPHI)
lyl314	Lyell Immunopharma, Inc. (LYEL)
Mosunetuzumab	BRISTOL MYERS SQUIBB CO (BMY)
nkx101	Nkarta, Inc. (NKTX)
onct-808	Oncternal Therapeutics, Inc. (ONCT)
polatuzumab vedotin	Karyopharm Therapeutics Inc. (KPTI)
reduced-dose hht	ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
regn17372+linvoseltamab	REGENERON PHARMACEUTICALS, INC. (REGN)
regn7945+linvoseltamab	REGENERON PHARMACEUTICALS, INC. (REGN)
standard-dose hht	ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
tafasitamab	Karyopharm Therapeutics Inc. (KPTI)
tak-573	Teva Pharmaceutical Industries Limited (TEVA)
zugo-cel	CRISPR Therapeutics AG (CRSP)

Phase 4(11)

Drug	Company
Acalabrutinib	ASTRAZENECA PLC (AZN)
bms-986369	BRISTOL MYERS SQUIBB CO (BMY)
BMS-986393	BRISTOL MYERS SQUIBB CO (BMY)
BMS-986458	BRISTOL MYERS SQUIBB CO (BMY)
BMS-986525	BRISTOL MYERS SQUIBB CO (BMY)
ixazomib	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
mRNA-2808	Moderna, Inc. (MRNA)
ofatunumab	Novartis AG (NVS)
Tislelizumab	ENANTA PHARMACEUTICALS INC (ENTA)
tocilizumab	REGENERON PHARMACEUTICALS, INC. (REGN)
Zanubrutinib	BeOne Medicines Ltd. (ONC)

Compare drugs

ABRAXANE vs arsenic tri ABRAXANE vs aucatzyl ABRAXANE vs bortezomib

Frequently asked questions

How many drugs are in development for Relapse?

BioSniper tracks 287 drugs in development for Relapse across 117 companies.

How many clinical trials target Relapse?

There are 5 clinical trials targeting Relapse tracked by BioSniper.

Deep-dive into Relapse

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis